Zimmer Biomet Wins Three Awards at Asia Pacific Medtech Awards

Zimmer Biomet Japan G.K. (Headquarters: Minato-ku, Tokyo; Executive Officer: Shio Uchida), the Japanese subsidiary of Zimmer Biomet, a global leader in the Medtech industry, announced that it has won three awards at the Healthcare Asia Medtech Awards 2026, presented in Singapore on March 27, 2026 (local time). The awards were for Orthopedic Product Innovation, Digital Innovation, and Marketing & Communications.

## Award Categories

* **Orthopedic Product Innovation Award (Japan)**
* "iTaperloc® Complete / iG7™ Hip System" artificial hip implants utilizing "iTechnology" (iodine treatment technology).

* **Digital Innovation of the Year (Australia)**
* "WalkAI," an AI-powered digital platform for tracking recovery after total knee arthroplasty.

* **Marketing & Communications Initiative of the Year (Thailand)**
* The "You'll Be Back" disease awareness campaign featuring Arnold Schwarzenegger as "Chief Movement Officer."

## Comment from Asia Pacific Group President

San Yi, Zimmer Biomet's Asia Pacific Group President, stated:
"These awards are a testament to Zimmer Biomet's strong innovation capabilities in the Asia Pacific region and the recognized importance of our solutions. From addressing infection risks with advanced implant technology to data-driven recovery support and strengthening collaboration with surgeons, we are focused on solving the most critical healthcare challenges and improving patient outcomes across the region."

## About Healthcare Asia Medtech Awards

The Healthcare Asia Medtech Awards, organized by Healthcare Asia Magazine, a medical professional media outlet in Singapore, is an awards program that recognizes companies and initiatives that have achieved innovative results and social impact in the medical device, digital health, and patient care solutions sectors across the Asia Pacific region, on a country-by-country basis. It consists of 16 categories, including Product Innovation, Digital Innovation, and Marketing & Communications Initiative.

## Orthopedic Product Innovation Award: Artificial Hip Implants with "iTechnology" (Iodine Treatment Technology)

The iTaperloc® Complete and iG7™ Hip System, which utilize "iTechnology" (iodine treatment technology), are artificial hip implants equipped with infection control technology that inhibits bacterial adhesion and biofilm formation on the implant surface.

These implants are designed to inhibit bacterial adhesion [1-2] and aim to reduce the risk of periprosthetic joint infection, a serious complication estimated to occur in approximately 1% to 2% of primary surgeries [3].

Iodine is highly biocompatible and inhibits biofilm formation without increasing antibiotic resistance [4-5]. This technology received approval from Japan's Ministry of Health, Labour and Welfare in September 2025 and was designated as a Breakthrough Device by the U.S. Food and Drug Administration (FDA) in October of the same year.

## Digital Innovation of the Year: WalkAI Platform

WalkAI is a digital platform that uses artificial intelligence to analyze walking data of patients after total knee arthroplasty and predict walking speed on day 90 post-surgery. The period from day 15 to day 40 post-surgery is typically when patient contact with healthcare providers is minimal, but WalkAI is designed to detect patients whose recovery is not progressing as expected during this period, enabling early clinical intervention. By improving the visibility of recovery status, surgeons can prioritize patients who require more detailed monitoring or rehabilitation adjustments, leading to a reduction in the risk of complications.

This platform is currently used by over 180 surgeons in Australia and New Zealand, supporting over 20,000 patients, demonstrating high adoption and scalability in clinical practice.

## Marketing & Communications Initiative of the Year: "You'll Be Back"